COR Development Featured in COMO Business Times for ABK Biomedical Project
COR Development was recently featured in COMO Business Times for the construction launch of ABK Biomedical’s new facility at Cartwright Business Park in Ashland, Missouri.
The nearly 17,000-square-foot facility marks an exciting investment in mid-Missouri and will support the commercial manufacturing of ABK Biomedical’s Eye90 microspheres, a Yttrium-90 medical device therapy being developed to treat liver cancer.
COR Development is working alongside ABK Biomedical, Coil Construction and the University of Missouri Research Reactor (MURR) to bring the project to life. The existing building at Cartwright Business Park will be transformed into a specialized life sciences and manufacturing facility designed to support ABK Biomedical’s future commercial operations.
The location in Ashland also puts ABK Biomedical near MURR, which will serve as the primary irradiation partner for Eye90 microspheres. Together, the project brings development, construction, research and medical innovation together in mid-Missouri.
For COR Development, the project represents the kind of opportunity Cartwright Business Park was created to support — providing space for companies to invest, grow and create new opportunities in the region.
The construction launch brought together project partners, community leaders and state and local officials to celebrate the project and the continued growth taking place in Boone County.
COR Development is excited to welcome ABK Biomedical to Cartwright Business Park and looks forward to seeing the facility and partnership take shape.
Read the full story from COMO Business Times: HERE
